ESG resolution round-up: Investors win disclosure on vaccine pricing at Moderna & Pfizer

Disclosure by pharma giant prompts withdrawal of proposals, including LGIM’s

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.